Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin for Reduction of Vascular Stiffness in Middle-aged Men
ChiCTR2300076294Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in arteriosclerosis comparing Terazosin 0.5 mg with Placebo (2 arms). Primary endpoint: Brachial-ankle pulse wave velocity. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
terazosin
03
Conditions
arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2300076294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076294.